Acceleron Pharma Inc (XLRN) Q3 2020 Earnings Call Transcript
XLRN earnings call for the period ending September 30, 2020.
Acceleron Pharma
XLRN
XLRN
$126.19
-$0.78
-0.6%
Price as of January 15, 2021, 9:00 p.m. EST
View Interactive XLRN Charts
CONTROLADORA VUELA SPON ADR REPR 10 CPOS
Interactive Chart
News & Analysis: Acceleron Pharma
Acceleron Pharma Inc (XLRN) Q2 2020 Earnings Call Transcript
XLRN earnings call for the period ending June 30, 2020.
Acceleron Pharma Inc (XLRN) Q1 2020 Earnings Call Transcript
XLRN earnings call for the period ending March 31, 2020.
Forget Coronavirus Stocks: Buy This One Instead
Here's why Acceleron Pharma is a better buy than both Moderna and Inovio Pharmaceuticals.
Better Buy: Geron vs. Acceleron
In this David versus Goliath battle, which biotech offers investors a greater return?
3 Top Biotech Stocks to Buy in March
Acceleron Pharma, Novavax, and TG Therapeutics are all on the cusp of hitting major milestones.
Acceleron Pharma Inc (XLRN) Q4 2019 Earnings Call Transcript
XLRN earnings call for the period ending December 31, 2019.
2 Top Biotech Stocks to Buy Right Now
These companies could crush the broader markets this year.
Why Acceleron Pharma Stock Bolted Higher in January
Acceleron's shares skyrocketed last month after its experimental PAH drug hit the mark in a midstage trial.
Is Acceleron Pharma Stock a Buy?
The stock's price surged following a clinical trial success, but should investors now temper their enthusiasm?
